Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.
Simple Summary: Immunotherapy has become part of the main treatment for non-small cell lung cancer. However, it pertains with immunotherapy-related inflammation of the lungs, an uncommon but potentially life-threatening side effect. Identification of patients at risk, early detection, and treatment...
| Publicado en: | Current Oncology Vol. 33; no. 5; pp. 240 - 256 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
May2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |